Improving the Potency of Cancer Immunotherapy by Dual Targeting of IDO1 and DNA-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improving the Potency of Cancer Immunotherapy by Dual Targeting of IDO1 and DNA

Published:2017-12-18 Issue:1 Volume:13 Page:30-36
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Fang Kun¹²,Dong Guoqiang²,Wang Hongyu²,He Shipeng¹,Wu Shanchao²,Wang Wei¹³,Sheng Chunquan²^ORCID

Affiliation:

1. School of Pharmacy; East China University of Science and Technology; Shanghai 200237 P.R. China

2. Department of Medicinal Chemistry, School of Pharmacy; Second Military Medical University; 325 Guohe Road Shanghai 200433 P.R. China

3. Department of Chemistry and Chemical Biology; University of New Mexico; Albuquerque NM 87131-0001 USA

Funder

National Key R&D Program of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Reference27 articles.

1. The future of immune checkpoint therapy

2. T cell exclusion, immune privilege, and the tumor microenvironment

3. Human tumor antigens recognized by T lymphocytes.

4. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enriched 10B-diboron reagents synthesis from 10BF3;Chem;2023-11

2. Modulation of T cells by tryptophan metabolites in the kynurenine pathway;Trends in Pharmacological Sciences;2023-07

3. Study on electrochemical reduction mechanism of p-nitrophenylacetic acid prepared by electrocarboxylation;Journal of Electroanalytical Chemistry;2023-05

4. Small molecule-based immunomodulators for cancer therapy;Acta Pharmaceutica Sinica B;2022-12

5. Dual-target inhibitors of indoleamine 2, 3 dioxygenase 1 (Ido1): A promising direction in cancer immunotherapy;European Journal of Medicinal Chemistry;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3